Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in COYA — Coya Therapeutics, Inc.

CIK 1214717 BOSTON, MA
Back to COYA Full portfolio

Position in COYA

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,335,221
+$415,618 QoQ
Shares Held
228,243
-2.2% QoQ
Ownership
0.973%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 54 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in COYA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. COYA ranks #303 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in COYA

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,335,221 228,243
2026-03-31 $919,603 233,402
2025-12-31 $1,148,330 197,988
2025-09-30 $894,015 156,845
2025-06-30 $903,249 157,087
2025-03-31 $1,008,213 155,829
2024-12-31 $862,800 150,576
2024-09-30 $917,892 142,309
2024-06-30 $835,212 137,824
2024-03-31 $1,249,880 125,996
2023-12-31 $685,165 92,465
2023-09-30 $334,329 87,065
2023-06-30 $238,392 58,573